51062-14-7: Dobutamine EP Impurity C
It is a tri methoxy precursor and impurity of Dobutamine which is a synthetic catecholamine synthesized as a selective positive inotropic compound for short-term parenteral ingestion. Dobutamine’s effects are controlled by strong beta1adrenergic receptor stimulation and mild potentiation of beta2 and alpha1 receptors.
Additional information on CAS 51062-14-7
VE006420
51062-14-7
C21H30ClNO3
379.92
Dobutamine
(2RS)-N-[2-(3, 4-Dimethoxyphenyl)ethyl]-4-(4-methoxyphenyl)butan-2-amine hydrochloride
N/A
Pallavicini, Marco, et al. “Synthesis, Free Solution Capillary Electrophoresis Separation and Toxicity of Seven Potential Impurities of Dobutamine.” Arzneimittelforschung, vol. 51, no. 01, Dec. 2011, pp. 18–23, https://doi.org/10.1055/s-0031-1299997.?“Drugs Five Years Later: Dobutamine: Annals of Internal Medicine: Vol 99, No 4.” Annals of Internal Medicine, 2021, http://www.acpjournals.org/doi/abs/10.7326/0003-4819-99-4-490.?
In-stock
